Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CMIC Group Establishes CMIC BIO | Contract Pharma
Breaking News

CMIC Group Establishes CMIC BIO

Single-use facility in Shizuoka, Japan will provide process development and GMP manufacturing of antibody drugs using mammalian cell line.

CMIC HOLDINGS Co., Ltd. has established CMIC BIO Co., Ltd., a fully-owned subsidiary that offers Contract Development and Manufacturing Organization (hereinafter CDMO) services for biopharmaceutical drug substance. CMIC Bio has a single-use facility in Shizuoka, Japan for process development and GMP manufacturing of antibody drug using mammalian cell line. The facility will be fully operational beginning October 2020.

For the period from April 2014 to September 2019, CMIC JSR Biologics Co., Ltd. participated in the Japan Science and Technology Agency’s Program (NexTEP) (Project name: design and  manufacturing technology of multispecific antibodies). “Research has been conducted in the fields of manufacturing and quality control of biotechnology-derived pharmaceuticals, with a focus on the manufacturing process development of bispecific antibodies. Based on these experiences, we established CMIC Bio and the biopharmaceutical drug substances CDMO business.” At CMIC Bio, we have personnel with abundant experience at pharmaceutical companies and have strengths in GMP API manufacturing bases in Japan to assist in accelerating the development speed of biopharmaceuticals,” said Hiroshi Kosaku, President of CMIC Pharmaceutical Sciences.

CMIC Group provides services from non-clinical testing, clinical trials, GMP manufacturing of biopharmaceuticals to commercialization and post market.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters